逸達生物科技 Foresee Pharmaceuticals Co., Ltd.
About Us
Company Profile
Business Model
Board of Directors
Management Team
Scientific Advisory Board
Others
R & D
Pipeline Overview
SIF Pipeline
FP-001：Prostate Cancer; Central Precocious Puberty
FP-014：Prostate Cancer
FP-016：Neurology/Psychiatry
FP-004：Opioid Dependence/Pain
FP-011：Breast Cancer
Other Research Projects
NCE Pipeline
FP-025：Asthma; COPD/ILD
FP-045: Fanconi Anemia; Pulmonary hypertension associated with interstitial lung disease (PH-ILD); Cardiovascular, Renal and Metabolism (CVRM); Peripheral artery disease (PAD)
FP-020: Sarcoidosis, Idiopathic pulmonary fibrosis (IPF), emphysema
FP-040: CNS Diseases
Media
Press Release
Media Library
Investors
Corporate Governance
Corporate Charters
Board of Directors
Others
Material Information
News & Events
Press Releases
Events & Presentations
Financial Information
Financial Results
Monthly Revenues
Sharholder Information
Annual General Meeting
Major Shareholders
FAQs
Investor Contacts
Others
Career
Benefits
Join Us
Contact Us
繁體中文
HOME
繁體中文
HOME
Investors
News & Events
Press Releases
Events & Presentations
